Barclay C. HPV vaccination significantly reduces cervical disease. Practitioner April 2019;263(1825):5

HPV vaccination significantly reduces cervical disease

24 Apr 2019Registered users

A landmark study from Scotland has shown that bivalent HPV vaccine confers significant protection against cervical epithelial dyskaryosis and dysplasia, both precursors of invasive cervical cancer. This study reports statistically significant reductions in all grades of CIN, equating to vaccine effectiveness estimates of 80% or greater after routine immunisation of girls at age 12-13 years.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article